Infant Probiotic Use may Reduce Risk of Gastrointestinal Disorders

Various studies have shown the beneficial effects of probiotics. Yet a recent study emphasizes the effects of such micro-organisms on infants. Research shows that it may help reduce the risk of certain gastrointestinal disorders.

According to a new study of 554 newborns in Italy, infants were given the probiotic Lactobacillus reuteri during the first three months of life. Researchers found that they were less likely to suffer from common gastrointestinal disorders, including acid reflux, infant colic and constipation.

Researchers looked at babies in nine pediatric units throughout Italy who received either the probiotic Lactobacillus reuteri DSM 17938 (L reuteri DSM 17938) or a placebo for 90 days. The parents were asked to document the number of vomiting episodes and bowel evacuations, as well as any inconsolable crying fits and the number of pediatrician visits. All of the episodes were recorded as well as changes due to the cost benefits of probiotic supplement use during the 90-day period.

Findings showed that probiotic use reduced the average crying time as well as regurgitations and evacuations per day. Their use was even linked to $119 average savings per patient in each family.

In an editorial that accompanied the study, Dr. Bruno Chumpitazi and Dr. Robert Shulman of the Baylor College of Medicine both called the results "encouraging." However, they also suggested that future studies needed to follow children over several years to determine the long-term use of probiotics during infancy.

More information regarding the study can be found via the journal JAMA Pediatrics.